Literature DB >> 24142474

Classification and pathology of primary progressive aphasia.

Jennifer M Harris1, Claire Gall, Jennifer C Thompson, Anna M T Richardson, David Neary, Daniel du Plessis, Piyali Pal, David M A Mann, Julie S Snowden, Matthew Jones.   

Abstract

OBJECTIVE: We aimed to determine the extent to which patients with progressive language impairment conform to 2011 primary progressive aphasia (PPA) classification and to examine clinicopathologic correlations within PPA variants.
METHODS: Sixty-two consecutive patients with pathologically confirmed dementia who presented clinically with aphasia were identified. Patients with insufficient clinical information were excluded. PPA classifications were applied to anonymized clinical data taken from patients' initial assessment by raters who were blinded to clinical and pathologic diagnosis.
RESULTS: The final cohort comprised 52 patients, 30 of whom met basic PPA criteria. Twenty-five patients met one of the 3 PPA classifications (13 logopenic, 8 nonfluent/agrammatic, and 4 semantic). Five patients did not meet the criteria for any of the PPA variants. All patients who met semantic variant PPA and 75% of patients who met nonfluent/agrammatic variant PPA classifications had frontotemporal lobar degeneration spectrum pathology. Pathologies were heterogeneous in patients who met logopenic variant PPA criteria (46% Alzheimer disease [AD], 8% AD mixed with dementia with Lewy bodies, 23% frontotemporal lobar degeneration, and 23% other).
CONCLUSION: The 2011 PPA recommendations classify a large proportion of patients who meet basic PPA criteria. However, some patients had aphasic syndromes that could not be classified, suggesting that the 2011 recommendations do not cover the full range of PPA variants. Classification of semantic variant PPA provides a good prediction of underlying pathology. Classification of logopenic variant does not successfully differentiate PPA due to AD from PPA due to other pathologies.

Entities:  

Mesh:

Year:  2013        PMID: 24142474     DOI: 10.1212/01.wnl.0000436070.28137.7b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  74 in total

1.  Sleep talking and primary progressive aphasia: case study and autopsy findings in a patient with logopenic primary progressive aphasia and dementia with Lewy bodies.

Authors:  Alexandra Clemans Apple; Qinwen Mao; Eileen Bigio; Borna Bonakdarpour
Journal:  BMJ Case Rep       Date:  2019-05-27

Review 2.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 3.  Pathology in primary progressive aphasia syndromes.

Authors:  Jennifer M Harris; Matthew Jones
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

4.  Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes.

Authors:  Jordi A Matías-Guiu; María Nieves Cabrera-Martín; Teresa Moreno-Ramos; María Valles-Salgado; Marta Fernandez-Matarrubia; José Luis Carreras; Jorge Matías-Guiu
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

5.  Progressive agrammatic aphasia without apraxia of speech as a distinct syndrome.

Authors:  Katerina A Tetzloff; Joseph R Duffy; Heather M Clark; Rene L Utianski; Edythe A Strand; Mary M Machulda; Hugo Botha; Peter R Martin; Christopher G Schwarz; Matthew L Senjem; Robert I Reid; Jeffrey L Gunter; Anthony J Spychalla; David S Knopman; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

Review 6.  Speech and language therapy approaches to managing primary progressive aphasia.

Authors:  Anna Volkmer; Emily Rogalski; Maya Henry; Cathleen Taylor-Rubin; Leanne Ruggero; Rebecca Khayum; Jackie Kindell; Maria Luisa Gorno-Tempini; Jason D Warren; Jonathan D Rohrer
Journal:  Pract Neurol       Date:  2019-07-29

7.  Non-right handed primary progressive apraxia of speech.

Authors:  Hugo Botha; Joseph R Duffy; Jennifer L Whitwell; Edythe A Strand; Mary M Machulda; Anthony J Spychalla; Nirubol Tosakulwong; Matthew L Senjem; David S Knopman; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  J Neurol Sci       Date:  2018-05-07       Impact factor: 3.181

8.  Utility of Amyloid PET Scans in the Evaluation of Patients Presenting with Diverse Cognitive Complaints.

Authors:  Yat-Fung Shea; Warren Barker; Maria T Greig-Gusto; David A Loewenstein; Steven T DeKosky; Ranjan Duara
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 9.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

Review 10.  Primary Progressive Aphasias and Apraxia of Speech.

Authors:  Hugo Botha; Keith A Josephs
Journal:  Continuum (Minneap Minn)       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.